Introduction
Total joint replacement has become one of the most efficacious and cost-effective procedures to relieve pain and restore joint function of severe osteoarthritis and rheumatoid arthritis. Despite the popularity and initial success, aseptic loosening of prosthetic joint components remains a major problem for the long-term success and survival of the prosthetic joints. 1 A volume of evidence has indicated that particulate debris generated from implant wear plays a critical role in the pathogenesis of aseptic loosening. Macrophages and foreign-body giant cells are activated by the interaction and phagocytosis of particulate wear debris, and this cellular activation contributes to the periprosthetic osteolysis that accompanies implant loosening by both releasing proinflammatory cytokines and mediators that provoke osteoclastic activity and the differentiation of phagocyte precursors into osteoclastic bone-resorbing cells. 2, 3 Several proinflammatory cytokines known to stimulate osteoclastic bone resorption, such as interleukin-1 (IL-1), tumor necrosis factor a (TNFa), and IL-6, have been identified in periprosthetic tissues. [4] [5] [6] It is recognized that they are released from wear particle-stimulated macrophages and fibroblastic cells. 7, 8 These mediators have been implicated in the inflammatory response to wear particles and the osteolysis of aseptic loosening. A recent study showed a positive correlation between cytokine concentration in cells found in the loosening membrane and the degree of underlying osteolysis. 9 Therefore, inhibition of proinflammatory cytokine activities at the interface between prosthetic component and surrounding bone may stop or retard the bone resorption and implant loosening process. We have previously reported that in vivo gene transfers of inhibitory or anti-inflammatory cytokines such as human interleukin-1 receptor antagonist (IL-1Ra) and viral IL-10 effectively ameliorated orthopedic biomaterial-induced local inflammation in synovial-like murine air pouch membranes. 10, 11 To investigate the relationship of inflammatory periprosthetic pseudomembrane and bone resorption and potential therapeutic approaches, we recently developed a novel murine model of debris-induced osteolysis. 12, 13 The current study is an extension of our previous investigations to examine the protective effects of antiinflammatory cytokine gene transfers on ultra-highmolecular-weight polyethylene (UHMWPE) particle-induced bone resorption in this novel murine model.
Results

Gene transduction and expression
The murine model of bone resorption used in this study was modified from the air pouch model reported previously. [14] [15] [16] Briefly, after the establishment of air pouches on the back of mice by repeated subcutaneous injection of air, a segment of femur or calvarium was implanted into the air pouch, followed by introduction of the most common orthopedic wear debris component, UHMWPE particles, into the air pouch of each mouse. The mice were divided into four groups and received, by injection into the pouches respectively, retrovirus encoding for interleukin-1 receptor antagonist (hIL-1Ra), 17 viral interleukin-10 (vIL-10), 18 bacterial galactosidase (LacZ), 17 or virus-free medium 24 h later. Both retroviral vectors encoding for hIL-1Ra and vIL-10 also contained a selectable gene marker, neo gene. All mice were killed 7 days post the in vivo gene transduction. The transduction and expression of the exogenous genes was determined using conventional polymerase chain reaction (PCR) performed with primers specific for the neo gene. Positive PCR bands were observed in DNA extracted from the pouch membranes transduced with DFG-IRAPneo or DFG-vIL-10-neo, while DNA extracted from either nonviral control pouch membranes or membranes infected with MFG-LacZ were consistently negative ( Figure 1c ). X-gal staining on MFG-LacZ-transduced pouches revealed that 30-50% of cells expressed strong blue coloration, in contrast to the background stains for the nonviral control pouches, suggesting a satisfactory transduction efficacy for the retroviral vectors (Figure 1a and b). The production of human IL-1Ra or viral IL-10 protein subsequent to the integration of the transgene was determined using enzyme linked immunosorbent assay (ELISA) with the anti-human IL-1Ra or anti-viral/ human IL-10 antibodies that do not crossreact with murine IL-1Ra and IL-10. The therapeutic transgene products averaged 464.7728 and 308.2770 pg/mg in pouch fluids for hIL-1Ra and vIL-10, respectively, at the time of killing.
Amelioration of UHMWPE-induced local inflammation by gene transfers
Proinflammatory cytokine expressions were determined by both RT-PCR and ELISA techniques. Immediately after harvesting the particles-bone-implanted pouches from mice, a section of the inflammatory pouch membrane was separated from attached bone implant and snap-frozen for RNA isolation and protein preparation. Real-time PCR and ELISA techniques were performed to assess the anti-inflammatory effects of gene transfer of either hIL-1Ra or vIL-1 in this model. Expressions of major proinflammatory cytokines were determined as shown in Figure 2 . The change in IL-1 expression at 7 days after virus infection is illustrated in Figure 2a . Either hIL-1Ra or vIL-10 gene transfer significantly suppressed IL-1 expression in pouch membranes at both the mRNA and protein levels. IL-10 gene modification also significantly inhibited TNFa mRNA expression, while no significant statistical difference was 
Protective effects of gene modification on osteolysis
The relationships between the amelioration of inflammation by gene transduction and protective effects on bone preservation were examined by image analysis. The assessment indicated that both anti-inflammatory cytokine gene transfers markedly reduced the occurrence of bone pit erosions along the bone surfaces in contact with inflammatory membranes. The insets of Figure 3 show the bone-membrane interface at high magnification, revealing osteoclast-induced bone pit erosions on the sections from the virus-free and LacZ controls (Figure 3a and b). Gene transfers of either hIL-1Ra (Figure 3c ) or vIL-10 ( Figure 3d ) dramatically protected against the formation of bone pit erosions. Furthermore, the changes in bone collagen content indicated a protective effect due to the gene modifications. The bone collagen degradation at the bone surface in contact with inflammatory pouch membrane was clearly revealed using modified Masson's trichrome stain by a reduction of blue staining. 12 A computerized image analysis system was employed to quantify the collagen changes by comparing the integrated color density difference on modified trichromestained sections. The measurements indicated that therapeutic gene transfer significantly protected against collagen loss from bone areas in close contact with inflammatory membranes, in comparison with similar regions in LacZ-transduced sections and in virus-free controls (Po0.05, Figure 4 ). There was no significant difference in bone collagen loss between LacZ-transduced and nonviral groups. Protection against bone resorption by gene transfer of either hIL-1Ra or vIL-10 in the bone-implanted pouch was also evaluated by inhibition of the bone calcium release into the pouch fluid. Free calcium ion appeared undetectable in lavage fluids from air pouches without bone implantation. 19 In this study, a mean calcium concentration of 100 nmol was detected in the fluid from virus-free and LacZ control groups, while a significant reduction in free calcium level in the fluid from pouches transduced with IL-1Ra was observed (Po0.05, Figure 5 ). Although there was a trend toward calcium ion reduction in the lavage fluids from vIL-10 gene-modified bone pouches, these results failed to achieve statistical significance.
Regulatory effects of gene transfers on osteoclastogenesis
Real-time PCR was performed to evaluate the influence of anti-inflammatory cytokine gene transfers on osteoclastogenesis in this model. Transduction of either inhibitory cytokine transgene significantly reduced the mRNA expression of the osteoclastogenesis regulator macrophage colony stimulating factor (M-CSF) by 70-90% (Po0.05, Figure 6a ) in comparison to the LacZ-or virus-free controls. The gene expression of receptor for activation of NF-kB (RANK) was also diminished by more than 65% following IL-1Ra or IL-10 gene modification compared with control groups (Po0.05, Figure 6a ). There was, however, no significant difference among groups in the gene expression of RANK ligand (RANKL, Gene transfer of anti-inflammatory cytokines for osteolysis S-Y Yang et al Figure 6a ) and osteoprotegerin (OPG, data not shown) 7 days after viral infection. In addition, abolishment of calcitonin receptor and cathepsin K gene expression was observed due to hIL-1Ra or vIL-10 transduction. These reductions were significant when compared to the expression of these osteoclast markers in either LacZ transduction or virus-free controls (Po0.01, Figure 6b ). Histochemical TRAP staining was conducted to detect osteoclast-like cells. We observed that the requirement for decalcification of femur bone for histological processing interfered with quantification of TRAP staining, 19 and thus calvarium-implanted pouches with particle stimulation and transgene transduction were adopted in this study. Frozen sectioned calvarium-implanted pouches were stained to identify osteoclast-like cells following gene transfers. Gene
Discussion
Aseptic loosening is the single most common long-term complication following total joint arthroplasty. Wear debris associated local inflammation and consequent bone resorption are believed to play critical roles in the pathogenesis of the complication. Proinflammatory cytokines including IL-1, TNFa, and IL-6 secreted by debris-provoked macrophages, lymphocytes, and fibrocytes stimulate osteoclast differentiation and activation through a mechanism that appears dependent on some essential regulators, M-CSF and RANKL. 3, 20, 21 Therefore, periprosthetic osteolysis appears to consist of three major interacting events: (1) inflammation, (2) osteoclastogenesis, and (3) osteoclastic bone resorption. Blocking these processes may provide potential therapeutic approaches to prevent or retard the periprosthetic osteolysis and prolong the life of prostheses. 22 We have proposed that the inhibition of proinflammatory cytokines represents a potential therapy to reduce chronic inflammation provoked by wear debris in the periprosthetic tissue. Current systemic anti-inflammation therapies have several weaknesses, including high-dose requirements with modest efficiency, systemic side effects, and tendency for poor patient compliance. 23 Gene therapy offers a novel approach to treat chronic inflammation that avoids most of the weaknesses of the conventional therapies. 23 By directly delivering the genes encoding for anti-inflammatory cytokine proteins to the local sites, gene transfers may provide a relatively sustained therapeutic effect to match the persistence of the inflammation and reduce side effects caused by systemic administration. Many studies have published recently using gene transfers for chronic inflammatory diseases including rheumatoid arthritis and wear debris-induced inflammation and osteolysis. [24] [25] [26] We noticed that some severe side effects related to retroviral vector transfers in clinical trials have been observed, and the Food and Drug Administration (USA) have put protocols involving retroviral gene therapy on clinical hold until further assessment of risk to patients have been performed. Although not very clear, the complication of cancer or leukemia following retroviral transduction might be due to the insertion of retroviral genes into the host cell's chromosomes near a cellular gene that regulates growth. The purpose of the current study was to extend our previous investigation to examine the anti-inflammatory cytokine gene transduction in protecting against orthopedic biomaterialassociated osteolysis; the safety issue of retroviral vectors will be explored in additional studies.
Similar to our previous findings, 11 in vivo therapeutic gene transfer of human IL-1Ra or viral IL-10 dramatically abolished the characteristic markers of UHMWPE particle-induced local inflammation. Findings included reduced pouch membrane thickness, decreased inflammatory cellular infiltration, and diminished expression and secretion of proinflammatory cytokines (IL-1 and TNF). Studies have shown that IL-1 and TNF are among the major cytokines detected in periprosthetic tissues, [4] [5] [6] and are known to be potent mediators of bone resorption by either acting directly as an osteoclast activating factor, 27, 28 or indirectly through a stimulatory effect on the production and activation of other potent mediators of bone lysis. 20, 29, 30 Therefore, blocking or diminishing the activity of proinflammatory cytokines should protect against the inflammatory bone resorption. Indeed, this study reveals that gene transfer of either hIL-1Ra or vIL-10 dramatically protected against particle-associated inflammatory bone resorption including the decrease of bone pit erosion, preservation of bone collagen content, and diminishment of bone mineral (calcium) loss.
IL-1 receptor antagonist (IL-1Ra) is a small molecule that inhibits the biological activities of IL-1 by occupying the type I IL-1 receptor without eliciting a signal transduction response. 31 Although IL-4 has been reported as protecting against cartilage and bone destruction in an animal model of arthritis by stimulating IL-1Ra synthesis and secretion, 32 many investigators believed that it was difficult to use IL-1Ra in vivo due to its poor pharmacokinetics and the requirement to occupy fully IL-1 receptor on the cell surface for prolonged periods of time. 33 Local gene transfer of IL-1Ra, however, may provide the means to deliver sufficient therapeutic protein to the site. Our data showed that IL-1Ra transgene product remained at comparable levels for 7 days after viral infection, which resulted in marked protective effects against UHMWPE-induced bone resorption. In addition to IL-1Ra, IL-10 represents another potent anti-inflammatory cytokine that plays a major role in suppressing the inflammatory response, especially inflammation associated with cell-mediated immunity due to Th1 responses. 34 Studies have indicated that IL-10 decreases the secretion of the proinflammatory cytokines IL-1, IL-6, IL-8, TNFa, and GM-CSF by monocytes/ macrophages, while increasing the production of IL-1Ra and inhibiting the production of PGE 2 . 35 In this study, elevated vIL-10 expression dramatically reduced the incidence of bone pit erosions and bone collagen degradation, along with marked anti-inflammatory effects. Carmody et al 22 recently published findings, which show that systemic viral IL-10 gene transfer completely blocked titanium particle-induced calvaria bone resorption, which is in agreement with current results. 
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It is widely accepted that the removal of mineralized bone matrix (bone lysis) requires direct cellular action, which in physiological bone remodeling is mediated by osteoclasts. 36 Several studies have indicated that osteoclasts are the main cells in bone resorption of aseptic loosening. 2, [37] [38] [39] Recently, two essential regulators have been identified in osteoclastogenesis: M-CSF and RANKL. 40, 41 In vitro studies have shown that in the presence of M-CSF, exogenous RANK ligand effectively induced osteoclast differentiation of progenitors derived from mouse bone marrow cells, spleen cells, or human peripheral blood mononuclear cells in the absence of stromal cells/osteoblastic cells. This suggests that RANKL and M-CSF induce osteoclast formation by direct activation of osteoclast progenitors. 42, 43 Xu et al 44 performed immunohistological experiments to identify M-CSF-expressing cells in periprosthetic pseuodomembranes around loosed total joint replacement and found that dramatically increased M-CSF-positive cells were present in the interface and pseudocapsular tissue compared to synovial tissue, indicating a significant role for M-CSF in the pathogenesis of loose implant.
Hamilton and others 45, 46 reported that many types of cells produce M-CSF in response to IL-1 and TNF. In the current study, transduction of human IL-1Ra and viral IL-10 significantly diminished M-CSF mRNA expression, effectively blocked osteoclast differentiation and maturation, and thus protected against osteolysis. This inhibition of osteoclastogenesis was confirmed by the reduction of TRAP-positive osteoclast-like cells, and suppression of osteoclast-specific makers calcitonin receptor (CTR), cathepsin K (CPK), and RANK. 47 However, we could not determine whether the gene transfers have any influence on RANK ligand expression. Nevertheless, the in vivo gene transfer of human IL1Ra or viral IL-10 effectively blocked orthopedic biomaterial-induced local inflammation, and subsequently protected against bone resorption by inhibiting osteoclast formation and maturation.
Materials and methods
Animals and materials
BALB/c mice aged 7-10 weeks were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and quarantined in our local facility for 2 weeks prior to experimentation. All mice weighed at least 20 g at the start of the experiment. Retroviral vectors encoding for human IL-1Ra (DFG-IRAP-neo), viral IL-10 (DFG-v-IL-10-neo), or b-galactosidase (MFG-LacZ) were constructed and maintained in Dr Robbins' laboratory in Pittsburgh, PA. 10, 17 Both DFG retroviral vectors also contained a gene marker neo. UHMWPE particles were generously provided by Dr John Cuckler (University of Alabama, Birmingham, AL, USA). Particle analysis with a Coulter Multisizer II (Coulter Electronics, Hialeah, CA, USA) and a scanning electron microscope demonstrated that more than 95% of the particles were less than 7 mm in diameter, with a mean size of 2.6 mm (ranged between less than 0.7 to 21 mm) and an aspect ratio of 0.984. Prior to injection into air pouches, the particles were tested for endotoxin contamination using a Limulus Amebocyte Lysate assay kit (LAL) (Endosafe, SC). Reverse transcription-polymerase chain reaction (RT-PCR) reagents including reverse transcriptase and AmpliTaq DNA polymerase were purchased from Perkin-Elmer (Norwalk, CT). Real-time PCR reagents including TagMan Universal PCR Master Mix, fluorescent VIC-labeled 18S primer/probe, and SYBR s Green PCR Master Mix were purchased from PE-Applied Biosystems, Foster City, CA, USA. The PCR primers and positive control (standards) for murine IL-1, IL-6, and TNFa were obtained from Clontech Laboratories, Inc. (Palo Alto, CA, USA), and the primer pairs for target genes of osteoclast marker (CTR, CPK, and RANK) and osteoclastogenesis regulators (M-CSF and RANKL) were picked up in sequences from GenBank, National Institute of Health (http://www.ncbi.nlm.nih.gov) 12 and constructed by Sigma Genosys Biotech (The Woodlands, TX, USA). Monoclonal antibodies against various cytokines for ELISA were obtained commercially from BD Biosciences (San Diego, CA, USA), except the capture and detection anti-hIL-1Ra antibodies (R&D Systems, Minneapolis, MN, USA) and the ELISA kit for mouse IL1b (BioSource, Camarillo, CA, USA).
Murine air pouch model of debris-induced osteolysis to evaluate gene transfer of inhibitory cytokines
The murine air pouch model of bone resorption used in this study was described previously, 12 and all the procedures were approved by the Animal Investigation Committee, Wayne State University. The dorsal area of BALB/c mouse was shaved, and 2.5 ml of filtered air was injected subcutaneously to establish a single air pouch. Filtered air (0.5 ml) was given every other day to maintain the pouch.
14 At 6 days after air pouch formation, a 0.6 cm section of femur (from the head to the shaft), or 0.5 Â 0.3 cm fragment of calvarium, from genetically identical mouse donors, was surgically inserted inside the pouch. Sterile phosphate-buffered saline (0.3 ml) containing 1:100 penicillin/streptomycin (Gibco BRL, Gaithersburg, MD, USA) was injected into the pouch, while the pouch layers and skin incisions were closed using 4-0 Prolene sutures. After 24 h, 1.5 Â 10 7 particles/ml of particulate UHMWPE suspension in 0.5 ml of 10% fetal bovine serum/saline were injected into the pouch to provoke inflammatory and osteolytic responses. The mice were divided into four groups the following day and were injected into the pouch, respectively, 0.5 ml of culture medium containing DFG-IRAP-neo, DFG-v-IL-10-neo, or MFG-LacZ at 10 6 particles/ml. The same volume of the medium without viral vector was injected into a group of virusfree control bone-implanted pouches. Previous studies have indicated that UHMWPE particles significantly increase pouch inflammation and bone implant resorption in comparison to pouches and implanted bones treated with FCS/saline vehicle alone; 19 hence, particlefree pouch controls were not included in this study. The mice were killed 7 days after viral infection, and both the pouch membrane and implanted bone tissue were harvested. A portion of air pouch with the intact bone implant was either snap-frozen (calvarium-implanted) for crystallized sectioning or fixed in 10% buffered formalin (femur-implanted) for paraffin embedding. Pouch fluid combined with 0.2 ml saline rinse of the remaining portion of pouch tissue was collected for determination of free calcium and cytokine production, before the remainder of the tissue was stored for molecular analyses.
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Histological evaluation
Formalin-fixed pouches with implanted bone were decalcified with formic acid/sodium citrate before paraffin-embedded and mounted with a consistent orientation and cut to 6 mm sections. The sections were stained with hematoxylin and eosin to examine bone erosion and changes of inflammatory parameters in the pouch membranes. Modified Masson's trichrome histological staining was performed to quantify the bone collagen content as a parameter of bone osteolysis. As described previously, 12 bone collagen acquired a blue stain, with the stain density proportionate to the collagen content. Histochemical tartrate-resistant acid phosphatase (TRAP) staining was performed to localize the osteoclast-like cells in the pouch tissue. 12 Briefly, cryosections at 8 mm thickness were prepared and fixed in buffered acetone for 30 s. The sections were incubated at 371C for 1 h in 100 mM acetate buffer (pH 5.2) containing 0.5 mM naphthol AS-BI phosphoric acid, 2.2 mM Fast Garnet GBC, and 8 mM sodium tartrate (Sigma, St Louis, MO, USA). The dark-purple-stained cells along the bone surfaces were quantified as TRAP-positive cells. X-gal staining was performed to confirm LacZ gene transduction as previously described. 10 In brief, frozen sections of bone-containing pouches were cut at 8 mm and fixed in 0.5% glutaraldehyde for 30 min, followed by incubating overnight in a mixture containing 1 mg/ml X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl 2 , and 0.02% of NP-40. The sections were washed next day and evaluated for the intensity and distribution of the blue coloration under a light microscope.
Image analysis
The images of various stained tissue sections were digitally photographed, and air pouch membrane thickness and cellular infiltration were quantified by a computerized image analysis system with the software 'Image-Pro Plus' (Media Cybernetics, Silver Spring, MD, USA) as described previously. 11 To determine changes of bone collagen content, Â 100 magnified digital images of modified Masson's trichrome-stained pouch sections containing femur implants were acquired. Image analysis was conducted to generate integrated optical densities (IOD) of the areas at the bone surface in contact with particle-stimulated inflammatory pouch membranes. The values were normalized against IODs obtained at inner parts of bone distal from pouch membranes. This self-normalization was conducted to diminish processing errors that could arise from differences in decalcification, sectioning, and staining. Six pairs of IOD readings at different regions of each bone section were averaged and at least six sections per group were analyzed. Due to the blurred boundaries of TRAP-positive cells in frozen sections and the difficulty in separating individual cells, the amount of TRAP-positive-stained osteoclast-like cells on the bone-membrane interface was compared and quantified in arbitrary units by the image analysis system according to area of the dark purple coloration per millimeter bone surface.
Molecular and immunological analyses
Pouch membranes were homogenized on ice using a polytron PT-MR2100 (Brinkmann Instruments, Inc., Westbury, NY, USA) operated at three bursts of 15 s. A fraction of the homogenate was processed for RNA/ DNA extraction using a commercial kit (Tel-Test Inc., Friendswood, TX, USA) in accordance with the manufacturer's instructions. The quantity and purity of the RNA and DNA were determined by spectrophotometric analysis at 260 and 280 nm wavelength. To examine transgene incorporation, conventional PCR was performed 11 on DNA extracted from pouch tissue infected with DFG-IRAP-neo or DFG-vIL-10-neo, with the specific primers for the neo sequence as published elsewhere. 10 The PCR was conducted for 35 cycles using a thermal cycler (Perkin-Elmer), with each cycle consisting of (1) denaturation at 941C for 1 min, (2) annealing at 601C for 1 min, and (3) extension at 721C for 1 min. Amplified neo PCR products were visualized under UV light after electrophoresis on 1.8% agarose gels containing ethidium bromide. Real-time RT-PCR was performed to assess the influence of gene transfer on osteoclastogenesis. Levels of mRNA expression of M-CSF, RANK/RANKL, calcitonin receptor, and cathepsin K in the pouch membranes were determined, and changes in the expression of proinflammatory cytokines including IL-1, TNF, and IL-6 were also examined, using a protocol and primer sequences published recently. 12 Briefly, 25 ml of reaction mixture including 2 ml cDNA, target gene primer pairs (at 400 nM final concentration), and 2.5 ml of 2 Â SYBR s Green Master Mix was run in a MicroAmp optical 96-well reaction plate with MicroAmp optical caps for 40 cycles (951C for 15 s and 601C for 1 min) in an ABI Prism 7700 Sequence Detector (Applied Biosystems). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts, a housekeeping gene, was run concomitantly on the same plate as an internal control to standardize target gene level with respect to variability in the quality of RNA and cDNA. The values of threshold cycle (Ct) at which a statistically significant increase in reporter-dye signals (DRn) was first detected were imported into Microsoft Excel s program and used to calculate the relative quantification of target gene expression. For IL-1 mRNA expression, a dilution series of a known copy number standard was included in the amplification process for absolute gene quantitation calculation. For target genes without known copy number standards, the comparative quantitation method was applied. With the Ct value of GAPDH as an internal control and the mean Ct value of target gene expression from virus-free control samples as the calibrator (named 0% expression change), the comparative quantification of target gene expression of the samples from LacZ, IL-1Ra, or vIL-10 was calculated according to the formula given in the manufacturer's manual. 48 ELISA was performed on pouch lavages to assess therapeutic transgene production and cytokine expression. The ELISA utilizes capture and detection monoclonal antibody pairs against different epitopes of the various cytokine molecules, and a standardized protocol was previously described. 4 The antibodies against human IL-1Ra and viral IL-10 can distinguish the transgene products from endogenous murine IL-1Ra and IL-10.
Mobilized calcium determination
Calcium concentration in the air pouch fluid was determined as a measure of bone demineralization, using an automatic fluorometric titration method in a Gene transfer of anti-inflammatory cytokines for osteolysis S-Y Yang et al fluorescent spectrophotometer (Model 810 Photomultiplier Detection System, Photon Technology International, NJ, USA) with fluorescent probe Fura-2 (Precision Systems). The concentration of calcium released from implanted bone was calculated according to Grynkiewicz et al 49 and expressed in nmol/l concentration.
Statistical analysis
The data from two independent experiments were analyzed for this study. A total of 46 animals sustained the experiments and there were at least nine animals for each group. Statistical analysis between groups was performed by the ANOVA test, with the Schafer formula for post hoc multiple comparisons, using the SPSS software package (SPSS, Chicago, IL, USA). A P-value of less than 0.05 was considered as significant difference. Data are expressed as mean7s.e. of the mean.
